Inozyme Pharma Cash Flow Statement 2019-2024 | INZY

Fifteen years of historical annual cash flow statements for Inozyme Pharma (INZY).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-71.17$-67.06$-56.62$-56.42$-19.72
$-4.61$-0.93$0.84$0.49$0.01
$8.18$8.22$7.54$20.07$0.30
$3.58$7.29$8.39$20.56$0.31
$0$0$0$0$0
$0$0$0$0$0
$-1.38$0.15$-0.68$2.10$-0.08
$-2.96$-1.00$-1.11$-6.14$-0.25
$-3.08$2.01$0.09$-0.11$0.60
$-70.68$-57.76$-48.15$-35.97$-18.81
$-0.30$-0.41$-0.40$-0.57$-0.14
$0$0$0$0$0
$0$0$0$0$0
$-53.35$-4.99$43.19$-116.61$-8.25
$0$0$0$0$0
$-53.35$-4.99$43.19$-116.61$-8.25
$0$0$0$0$0
$-53.65$-5.40$42.80$-117.18$-8.39
$40.00$4.05$0$0$0
$0$0$0$0$0
$40.00$4.05$0$0$0
$85.97$68.74$0.61$116$0.07
$85.97$68.74$0.61$150$22.97
$0$0$0$0$0
$0$0$0$0$0
$126$72.79$0.61$150$22.97
$1.63$9.60$-4.72$-3.34$-4.23
$7.04$7.67$7.16$2.31$0.30
$0$0$0$0$0